8-K

CME GROUP INC. (CME)

8-K 2021-05-10 For: 2021-05-05
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 10, 2021 (May 5, 2021)

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

Delaware 001-31553 36-4459170
(State or Other Jurisdiction<br> <br>of Incorporation) (Commission<br> <br>File No.) (IRS Employer<br> <br>Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading<br> <br>symbol Name of each exchange<br> <br>on which registered
Class A Common Stock CME Nasdaq

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (

see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its 2021 Annual Meeting of Shareholders on May 5, 2021 (the “Annual Meeting”).

At the close of business on March 8, 2021, the record date of the Annual Meeting, the Company had 359,056,196 shares of Class A and Class B common stock issued and outstanding. The following shares were present at the Annual meeting, either in person at the virtual shareholder meeting or by proxy.

Class(es) of Common Stock Aggregate No.<br>of Shares % of the<br>Issued and<br>Outstanding
Classes A and B 296,276,223 82.51 %
Class B-1 175 28.00 %
Class B-2 320 39.36 %
Class B-3 309 24.00 %
Class B-4 93 22.51 %

The results of the proposals are as follows:

1. The election of seventeen Equity Directors to serve until 2022 (elected by the Class A and Class B shareholders voting together as a single class):
Name Votes For Against Abstain
--- --- --- --- --- --- ---
Terrence A. Duffy 247,159,352 23,751,722 2,458,419
Timothy S. Bitsberger 257,961,211 15,081,204 327,078
Charles P. Carey 257,553,681 15,517,133 298,679
Dennis H. Chookaszian 256,357,277 16,692,322 319,894
Bryan T. Durkin 260,298,501 12,724,491 346,501
Ana Dutra 268,294,198 4,664,426 410,869
Martin J. Gepsman 252,207,306 20,811,707 350,480
Larry G. Gerdes 255,696,073 17,344,037 329,383
Daniel R. Glickman 219,859,522 50,001,771 3,508,260
Daniel G. Kaye 266,656,881 6,279,037 433,575
Phyllis M. Lockett 244,085,558 28,851,919 432,016
Deborah J. Lucas 270,752,621 2,191,894 424,978
Terry L. Savage 253,214,960 19,851,125 303,408
Rahael Seifu 271,669,471 1,272,392 427,630
William R. Shepard 258,212,621 14,830,058 326,814
Howard J. Siegel 259,339,392 13,694,251 335,850
Dennis A. Suskind 254,358,055 18,707,642 303,796

There were a total of 22,906,730 broker non-votes in this proposal.

2. The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2021 (ratified by the Class A and Class B shareholders voting together as a single class):
Votes For Votes Against Abstentions
--- --- ---
290,527,012 5,313,241 435,970
3. The approval, by advisory vote, of the compensation of the Company’s named executive officers (approved by the Class A and Class B shareholders voting together as a single class):
--- ---
Votes For Votes Against Abstentions
--- --- ---
246,577,868 25,639,350 1,152,275

There were a total of 22,906,730 broker non-votes in this proposal.

4. The election of Class B Directors:
a. In the election of the three Class B-1 Directors, no quorum was achieved. Therefore, William W. Hobert, Patrick J. Mulchrone and Robert J. Tierney Jr. are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2022 Annual Meeting or their earlier resignation or removal.
--- ---
Name Votes For Votes Against Abstentions
--- --- --- ---
William W. Hobert 156 8 11
Patrick J. Mulchrone 158 9 8
Robert J. Tierney Jr. 160 5 10
b. The election of two Class B-2 Directors to serve until 2022 from a slate of four nominees (the nominees in bold were elected by the Class B-2 shareholders):
--- ---
Name Votes For Votes Against Abstentions
--- --- --- ---
Michael G. Dennis 168 1 151
Yra G. Harris 89 1 230
Patrick W. Maloney 173 0 147
John (Jack) D. Newhouse Jr. 145 1 174
c. In the election of one Class B-3 Director, no quorum was achieved. Therefore, Elizabeth A. Cook is a “holdover” under Delaware law and the Company’s bylaws. She will continue to serve until her successor is duly elected at the 2022 Annual Meeting or her earlier resignation or removal.
--- ---
Name Votes For Votes Against Abstentions
--- --- --- ---
Elizabeth A. Cook 273 22 14

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CME Group Inc.
Registrant
Date: May 10, 2021 By: /s/ Kathleen M. Cronin
Name: Kathleen M. Cronin
Title: Senior Managing Director, General Counsel and Corporate Secretary